Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Spekulatius who wrote (22063)	6/11/1998 10:09:00 AM
From: Andreas Helke	Read Replies (2) of 32384

I don't know how you expect that development stage biotechs get their money? Doubling the shares since 1994 is standard operating procedure for development stage biotechs. The majority of them has doubled their shares in this time frame. Agouron which was recently used as an example of a company that cares about its shareholders and tries to minimize dilution did exactly the same as Ligand and doubled the number of shares since 1994. A company like Boston Life Sciences where you have reason to worry about dilution quadrupled the number of shares since then. Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next